Search

Your search keyword '"Perumal, Rubeshan"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Perumal, Rubeshan" Remove constraint Author: "Perumal, Rubeshan"
179 results on '"Perumal, Rubeshan"'

Search Results

2. Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial

9. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants

11. Brief Report: Differentiated Service Delivery Framework for People With Multidrug-Resistant Tuberculosis and HIV Coinfection

13. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

15. Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysis

20. Rapid Diagnosis of Drug-Resistant Tuberculosis–Opportunities and Challenges.

21. Drug-Resistant TB, HIV and COVID-19 Co-Infection: Case Reviews from Kwa-Zulu Natal, South Africa.

25. Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment

26. Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb

29. A cohort study of Post COVID-19 Condition across the Beta, Delta and Omicron waves in South Africa: 6-month follow up of hospitalised and non-hospitalised participants

30. INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial

31. Are We Capable of Unveiling the Missed Epidemic of Isoniazid-resistant Tuberculosis?

34. Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb.

36. An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)

37. Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis [Corrigendum]

38. Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis

39. Post COVID-19 Condition in South Africa: 3-month follow-up after hospitalisation with SARS-CoV-2

41. Post COVID-19 Condition in South Africa: 3-Month Follow-Up after Hospitalisation with SARS-CoV-2

42. The relationship between clinical trial participation and inhaler technique errors in asthma and COPD patients

43. A position statement and practical guide to the use of particulate filtering facepiece (N95, FFP2, or equivalent) respirators for South African health care workers exposed to respiratory pathogens including M. tuberculosis and SARS-CoV-2

44. A position statement and practical guide to the use of particulate filtering facepiece (N95, FFP2, or equivalent) respirators for South African health care workers exposed to respiratory pathogens including M. tuberculosis and SARS-CoV-2

45. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

46. The Relationship Between Clinical Trial Participation and Inhaler Technique Errors in Asthma and COPD Patients

47. An All-Oral 6-Month Regimen for Multi-Drug Resistant/Rifampicin-Resistant Tuberculosis: A Multi-Centre, Phase 3, Open Label, Randomised Controlled Trial (NeXT Study)

48. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Catalog

Books, media, physical & digital resources